High-fat diet rescues lethality of homozygous knock-in R155H VCP myopathic mice
高脂肪饮食挽救纯合敲入 R155H VCP 肌病小鼠的致死率
基本信息
- 批准号:8364893
- 负责人:
- 金额:$ 22.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:Amyotrophic Lateral SclerosisAnimal ModelAnimalsAutophagocytosisAutophagosomeBiochemicalBrainClinicalCoconut OilDevelopmentDietDiseaseDisease ProgressionExhibitsFatty AcidsFatty acid glycerol estersFrontotemporal DementiaGenesHeterozygoteHomozygoteHumanInclusion BodiesInheritedKnock-in MouseLaboratoriesLifeMethodsMitochondriaModelingMolecularMonitorMusMuscleMuscle WeaknessMutationMyoblastsMyocardiumMyopathyOsteitis DeformansPathogenesisPathologyPathway interactionsPatientsPhenotypeReportingSignal PathwaySignal TransductionSourceSpinal CordSystemTestingTherapeuticUbiquitinWeaningWeightdisease phenotypefeedinghuman diseasemitochondrial autophagymouse modelmulticatalytic endopeptidase complexmuscle strengthnoveloffspringpreclinical studypregnantprotein degradationpupresponsevalosin-containing protein
项目摘要
DESCRIPTION (provided by applicant): Our laboratory was the first to identify VCP mutations as a cause of hereditary inclusion body myopathy, Paget's disease of bone, frontotemporal dementia and amyotrophic lateral sclerosis, and has made progress in identifying the underlying molecular pathogenesis of these diseases. Studies of patients' myoblasts and the heterozygous R155H mouse have placed VCP at the intersection of the ubiquitin-proteasome signaling and autophagy pathways, both mechanisms being considered responsible for the intracellular protein degradation and abnormal pathology seen in muscle and brain. We have developed the first knock-in VCP mouse model carrying the common R155H mutation, which has many clinical features typical of the human disease (1). Unlike disease progression in the R155H heterozygous (VCPR155H/+) mouse model, homozygotes (VCPR155H/R155H) have a more severe muscle, brain and spinal cord pathology, with most surviving no more than 21 days. Homozygotes demonstrate an abnormal autophagic pathway and mitochondrial proliferation, as evidenced by structural and functional studies. Recent preliminary studies have shown that feeding pregnant heterozygous dams a diet with a 3% increase in fat results in a dramatic improvement in the survival of their homozygous offspring. These offspring live longer than 21 days and are successfully weaned, demonstrating that an increased fat diet ameliorates the lethal phenotype. In this application, we propose to investigate the optimum percentage of fat content on further rescuing the lethal phenotype. We will also study the important altered mitochondrial, autophagy and ubiquitin-proteasome molecular pathways in the homozygous VCP knock-in mice treated with normal versus high-fat diets. Studying this observation affords the opportunity to develop a promising therapeutic strategy for patients with VCP and related diseases.
PUBLIC HEALTH RELEVANCE: The knock-in homozygous VCP R155H knock-in mouse demonstrates more severe disease compared to the heterozygous R155H VCP mouse model and dies by 21 days. The mice have many of the pathological features typical of hereditary inclusion body myopathy, Paget disease of bone, frontotemporal dementia (IBMPFD) and ALS associated with mutations in the VCP gene. We have recently identified that we can rescue the lethal phenotype by feeding pregnant dams and pups a higher fat diet. This proposal offers the opportunity of utilizing the knock-in homozygous mice for the necessary preclinical studies before evaluating this promising treatment in patients with VCP disease.
描述(由申请人提供):我们的实验室是第一个将VCP突变识别为遗传性包容体肌病的原因,Paget的骨骼疾病,额颞痴呆和营养性侧面硬化症,并在识别这些疾病的潜在分子病原体方面取得了进展。对患者的成肌细胞和杂合R155H小鼠的研究已将VCP置于泛素 - 蛋白酶体信号传导和自噬途径的交集,这两种机制都被认为是造成肌肉内蛋白质降解和肌肉和大脑中异常病理的负责。我们开发了带有常见R155H突变的第一个敲入VCP小鼠模型,该模型具有许多人类疾病的许多临床特征(1)。与R155H杂合(VCPR155H/+)小鼠模型的疾病进展不同,纯合子(VCPR155H/R155H)具有更严重的肌肉,脑和脊髓病理学,大多数人存活不超过21天。纯合子表现出异常的自噬途径和线粒体增殖,如结构和功能研究所证明。最近的初步研究表明,喂养怀孕的杂合大坝的饮食脂肪增加了3%,从而显着改善了其纯合后代的生存。这些后代的寿命超过21天,并成功断奶,表明脂肪饮食的增加可以缓解致命的表型。在此应用中,我们建议研究进一步挽救致命表型的脂肪含量最佳百分比。我们还将研究用正常饮食与高脂饮食治疗的纯合VCP敲击小鼠中重要的线粒体,自噬和泛素 - 蛋白酶体分子途径。研究这一观察结果为VCP和相关疾病患者制定有希望的治疗策略提供了机会。
公共卫生相关性:与杂合R155H VCP小鼠模型相比,与纯合的VCP R155H敲击小鼠相比表现出更严重的疾病,并在21天后死亡。这些小鼠具有许多遗传包容体肌病,骨骼疾病,额颞痴呆(IBMPFD)的病理特征,以及与VCP基因突变有关的ALS。我们最近确定,我们可以通过喂养孕妇的大坝和更高的脂肪饮食来挽救致命的表型。该提案提供了利用纯合小鼠进行必要的临床前研究的机会,然后再评估VCP疾病患者的这种有希望的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIRGINIA Eunice KIMONIS其他文献
VIRGINIA Eunice KIMONIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIRGINIA Eunice KIMONIS', 18)}}的其他基金
Antisense oligonucleotide treatment for Pompe disease
庞贝病的反义寡核苷酸治疗
- 批准号:
10433785 - 财政年份:2022
- 资助金额:
$ 22.23万 - 项目类别:
Antisense oligonucleotide treatment for Pompe disease
庞贝病的反义寡核苷酸治疗
- 批准号:
10652582 - 财政年份:2022
- 资助金额:
$ 22.23万 - 项目类别:
Engineered AAV vectors for combinatorial treatment of rare genetic brain diseases
用于罕见遗传性脑部疾病组合治疗的工程 AAV 载体
- 批准号:
10414342 - 财政年份:2021
- 资助金额:
$ 22.23万 - 项目类别:
Translational Studies of Lipidomics-Associated Signaling Pathways in VCP Disease
VCP 疾病中脂质组学相关信号通路的转化研究
- 批准号:
8912058 - 财政年份:2014
- 资助金额:
$ 22.23万 - 项目类别:
High-fat diet rescues lethality of homozygous knock-in R155H VCP myopathic mice
高脂肪饮食挽救纯合敲入 R155H VCP 肌病小鼠的致死率
- 批准号:
8534709 - 财政年份:2012
- 资助金额:
$ 22.23万 - 项目类别:
INCLUSION BODY MYOPATHY ASSOPCIATED WITH APAGET DISEASE OF BONE AND FRONTOTEMPOR
与Apaget骨病和额颞叶病相关的包涵体肌病
- 批准号:
8166932 - 财政年份:2009
- 资助金额:
$ 22.23万 - 项目类别:
PRADER-WILLI SYNDROME AND EARLY-ONSET MORBID OBESITY NATURAL HISTORY CLINICAL PR
普瑞德威利综合征和早发性病态肥胖自然史临床公关
- 批准号:
8166923 - 财政年份:2009
- 资助金额:
$ 22.23万 - 项目类别:
CHARACTERIZATION OF FAMILIAL MYOPATHY, PAGET DISEASE OF BONE
家族性肌病、佩吉特骨病的特征
- 批准号:
8166942 - 财政年份:2009
- 资助金额:
$ 22.23万 - 项目类别:
PRADER-WILLI SYNDROME AND EARLY-ONSET MORBID OBESITY NATURAL HISTORY CLINICAL PR
普瑞德威利综合征和早发性病态肥胖自然史临床公关
- 批准号:
7951066 - 财政年份:2008
- 资助金额:
$ 22.23万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of UBQLN2 in neuronal dysfunction and ALS-FTD
UBQLN2 在神经元功能障碍和 ALS-FTD 中的研究
- 批准号:
10638277 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Physiological Function of Persistent Inward Currents in Motor Neurons
运动神经元持续内向电流的生理功能
- 批准号:
10663030 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats
通过等位基因特异性切除致病重复序列来纠正神经系统疾病
- 批准号:
10668665 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Age Differences and Mechanisms of Ketogenic Diet Induced Bone Loss
生酮饮食导致骨质流失的年龄差异和机制
- 批准号:
10740305 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Nanobodies targeting stress granule components
针对应激颗粒成分的纳米抗体
- 批准号:
10739370 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别: